NATICK, Mass., Launching a key clinical trial expected to serve as the foundation for global regulatory approvals, a physician in Auckland, New Zealand has performed the first patient implant of the ...

NATICK, Mass., Boston Scientific Corporation has completed enrollment in the SuperNOVA trial – a global, single arm, prospective, multicenter trial evaluating the long-term (12 month) safety and ...

Boston Scientific Corporation (NYSE: BSX) has received Food and Drug Administration (FDA) approval for the Innova™ Vascular Self-Expanding Stent System, an advanced treatment option for patients with ...

Medical device major Boston Scientific Corporation 's BSX self-expanding stent system - Innova Vascular - recently won marketing approval from the U.S. Food and Drug Administration (FDA). Subsequent ...

Circular RNA (circRNA) is not a new concept, but it is a novel strategy in the field of gene and cell therapy. While mRNA vaccines have revolutionized medicine, ...